Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

BACKGROUND: Previous proof-of-concept studies have shown that a short course of omalizumab can safely accelerate the oral immunotherapy schedule for multiple allergens simultaneously. Considering the high cost of medication, the dose-related efficacy of omalizumab at decreasing the duration of oral...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Allergy Asthma Clin Immunol
Main Authors: Langlois, Alexandra, Lavergne, Marie-Hélène, Leroux, Hélène, Killer, Kerstin, Azzano, Pauline, Paradis, Louis, Samaan, Kathryn, Lacombe-Barrios, Jonathan, Mâsse, Benoît, Des Roches, Anne, Bégin, Philippe
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7165401/
https://ncbi.nlm.nih.gov/pubmed/32328115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-020-00419-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados